N/A
Chewy, Inc., together with its subsidiaries, engages in the e-commerce business in the United States.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.26B↑ | $3.12B↑ | $3.10B↓ | $3.12B↓ | $3.25B |
| Gross Profit | $959.70M↑ | $928.20M↓ | $942.20M↑ | $923.80M↓ | $926.00M |
| Operating Income | $42.50M↓ | $65.20M↓ | $69.70M↓ | $76.90M↑ | -$9.71M |
| Net Income | $39.20M↓ | $59.20M↓ | $62.00M↓ | $62.40M↑ | $22.79M |
Chewy, Inc., together with its subsidiaries, engages in the e-commerce business in the United States. It offers pet food and treats, pet supplies and pet medications, and other pet-health products, as well as pet services. The company serves its cust...
While CHWY stock commands a significantly reduced premium to earnings, the discount narrative still needs work to be credible.
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.
Based on the average brokerage recommendation (ABR), Chewy (CHWY) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CHWY, FSM and MHO have been added to the Zacks Rank #5 (Strong Sell) List on June 26th, 2026.
In recent days, several major banks, including Citi, Goldman Sachs, TD Cowen, RBC and UBS, reiterated positive views on Chewy following its latest quarterly results, pointing to improving profitability, efficiency gains and multiple growth initiatives across advertising, healthcare and subscriptions. Analysts also highlighted Chewy’s expansion into pet healthcare and enhanced advertising platform as key levers that could deepen customer relationships and support margins over time, even as...